A carregar...
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
INTRODUCTION: Smoking drives substantial direct health care spending, comprising 8.7% ($168 billion) of annual United States aggregated spending. Smoking cessation (SC) prescription use is an effective strategy to improve health outcomes, increase quit rates, and reduce economic burden. However, pat...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6052927/ https://ncbi.nlm.nih.gov/pubmed/30038510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S165576 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|